Two Sigma Investments’s Seres Therapeutics MCRB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-32,328
| Closed | -$22.6K | – | 3332 |
|
2025
Q1 | $22.6K | Buy |
32,328
+7,916
| +32% | +$5.54K | ﹤0.01% | 3031 |
|
2024
Q4 | $20.3K | Buy |
+24,412
| New | +$20.3K | ﹤0.01% | 3042 |
|
2024
Q1 | – | Sell |
-349,588
| Closed | -$489K | – | 3146 |
|
2023
Q4 | $489K | Buy |
349,588
+337,559
| +2,806% | +$473K | ﹤0.01% | 2395 |
|
2023
Q3 | $28.6K | Buy |
+12,029
| New | +$28.6K | ﹤0.01% | 2774 |
|
2022
Q3 | – | Sell |
-336,056
| Closed | -$1.15M | – | 2617 |
|
2022
Q2 | $1.15M | Buy |
336,056
+207,904
| +162% | +$713K | ﹤0.01% | 1430 |
|
2022
Q1 | $912K | Buy |
128,152
+61,603
| +93% | +$438K | ﹤0.01% | 1713 |
|
2021
Q4 | $554K | Sell |
66,549
-932,867
| -93% | -$7.77M | ﹤0.01% | 1940 |
|
2021
Q3 | $6.96M | Buy |
999,416
+840,214
| +528% | +$5.85M | 0.02% | 740 |
|
2021
Q2 | $3.8M | Sell |
159,202
-50,699
| -24% | -$1.21M | 0.01% | 1033 |
|
2021
Q1 | $4.32M | Buy |
209,901
+69,391
| +49% | +$1.43M | 0.01% | 906 |
|
2020
Q4 | $3.44M | Buy |
140,510
+113,182
| +414% | +$2.77M | 0.01% | 867 |
|
2020
Q3 | $774K | Sell |
27,328
-131,121
| -83% | -$3.71M | ﹤0.01% | 1264 |
|
2020
Q2 | $754K | Buy |
158,449
+113,198
| +250% | +$539K | ﹤0.01% | 1262 |
|
2020
Q1 | $162K | Sell |
45,251
-66,332
| -59% | -$237K | ﹤0.01% | 1647 |
|
2019
Q4 | $385K | Buy |
111,583
+15,678
| +16% | +$54.1K | ﹤0.01% | 1788 |
|
2019
Q3 | $385K | Sell |
95,905
-75,328
| -44% | -$302K | ﹤0.01% | 1549 |
|
2019
Q2 | $551K | Buy |
171,233
+117,443
| +218% | +$378K | ﹤0.01% | 1560 |
|
2019
Q1 | $370K | Buy |
53,790
+35,721
| +198% | +$246K | ﹤0.01% | 1754 |
|
2018
Q4 | $82K | Buy |
+18,069
| New | +$82K | ﹤0.01% | 1972 |
|
2018
Q3 | – | Sell |
-24,798
| Closed | -$213K | – | 2212 |
|
2018
Q2 | $213K | Buy |
+24,798
| New | +$213K | ﹤0.01% | 1872 |
|
2018
Q1 | – | Sell |
-38,445
| Closed | -$390K | – | 2194 |
|
2017
Q4 | $390K | Buy |
38,445
+27,245
| +243% | +$276K | ﹤0.01% | 1847 |
|
2017
Q3 | $180K | Buy |
+11,200
| New | +$180K | ﹤0.01% | 1794 |
|